Sign up to save your podcasts
Or
Share October 2023 Editor’s Choice: OS updates for Imagyn50
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
October 2023 Editor’s Choice: OS updates for Imagyn50
Editor’s Choice Paper:
Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer
Hosted by:
Ursula Matulonis, MD, Associate Editor of Gynecologic Oncology
Featuring:
Kathleen N. Moore, MD, GOG-F and Stephenson Cancer Center at the University of Oklahoma Health Sciences Center
View all episodes
By Gynecologic Oncology
5
1818 ratings
Editor’s Choice Paper:
Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer
Hosted by:
Ursula Matulonis, MD, Associate Editor of Gynecologic Oncology
Featuring:
Kathleen N. Moore, MD, GOG-F and Stephenson Cancer Center at the University of Oklahoma Health Sciences Center
More shows like Listen to Gynecologic Oncology
View all
The NPR Politics Podcast
25,830 Listeners
Pod Save America
87,458 Listeners
The Daily
112,501 Listeners
Up First from NPR
56,536 Listeners
SGO on the GO
34 Listeners
John Mark Comer Teachings
1,808 Listeners
Good Hang with Amy Poehler
10,523 Listeners